IFNγ-dependent metabolic reprogramming restrains an immature, pro-metastatic lymphatic state in melanoma
- PMID: 41576931
- PMCID: PMC12930414
- DOI: 10.1016/j.ccell.2025.12.019
IFNγ-dependent metabolic reprogramming restrains an immature, pro-metastatic lymphatic state in melanoma
Abstract
Lymphatic vessels activate anti-tumor immune surveillance and support metastasis. Whether there are distinct lymphatic phenotypes that govern immunity and metastasis remains unclear. Here we reveal that cytotoxic immunity normalizes lymphatic function and uncouples immune and metastatic potential. We demonstrate that intratumoral lymphatic vessel density negatively correlates with cytotoxic immunity and that IFNγ reprograms the intratumoral lymphatic state. Lymphatic deletion of Ifngr1 expanded the intratumoral lymphatic network and drove the emergence of a tip-like state that promotes lymph node metastasis but not dendritic cell migration or response to immune checkpoint blockade (ICB). Mechanistically, IFNγ restrains proliferation and cell state programs through inhibition of mitochondrial respiration. Lymphatic-specific inhibition of mitochondrial complex III restrained the intratumoral tip-like state, blocked metastasis, and enhanced the response to ICB. Our data reveal that IFNγ induces a metabolic and phenotypic switch in tumor-associated lymphatic vessels that blocks regional metastasis and reinforces immune surveillance.
Keywords: immune checkpoint blockade; immune surveillance; interferon gamma; lymph node; lymphangiogenesis; lymphatic vessels; melanoma; metabolism; metastasis; oxidative phosphorylation.
Copyright © 2025 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests The authors declare no conflicts of interest.
Update of
-
IFNγ-dependent metabolic reprogramming restrains an immature, pro-metastatic lymphatic state in melanoma.bioRxiv [Preprint]. 2024 Dec 5:2024.12.02.626426. doi: 10.1101/2024.12.02.626426. bioRxiv. 2024. Update in: Cancer Cell. 2026 Jan 22:S1535-6108(25)00553-7. doi: 10.1016/j.ccell.2025.12.019. PMID: 39677662 Free PMC article. Updated. Preprint.
References
-
- Gengenbacher N, Singhal M, Mogler C, Hai L, Milde L, Pari AAA, Besemfelder E, Fricke C, Baumann D, Gehrs S, et al. (2021). Timed Ang2-Targeted Therapy Identifies the Angiopoietin-Tie Pathway as Key Regulator of Fatal Lymphogenous Metastasis. Cancer Discov 11, 424–445. 10.1158/2159-8290.CD-20-0122. - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
